loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Cysteamine Bitartrate

    Client Email Product
    Menu

    Cysteamine Bitartrate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 5Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 203389 / DOSAGE - CAPSULE, DELAYED RELEASE;ORAL - EQ 25MG BASE

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CYSTEAMINE BITARTRATE(UNII: QO84GZ3TST)
    (CYSTEAMINE - UNII:5UX2SD1KE2)     		CYSTEAMINE75mg | 25mg

    Inactive Ingredients

    Ingredient Name
    Raptor Therapeutics Inc.
    FD&C BLUE NO. 2(L06K8R7DQK)
    GELATIN, UNSPECIFIED(2G86QN327L)
    HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
    METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A(NX76LV5T8J)
    MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
    SODIUM LAURYL SULFATE(368GB5141J)
    TALC(7SEV7J4R1U)
    TITANIUM DIOXIDE(15FIX9V2JP)
    TRIETHYL CITRATE(8Z96QXD6UM)
    WATER(059QF0KO0R)